Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Items » Feiba 1000IU


May be acceptable
If it is considered to be clearly essential

Contraindicated
Feiba 1000IU :
Type Medicine Authorised
Originator B
Agent Abela Freres
Distributor Abela Freres
Laboratory Baxter
Responsible Party Baxter AG
Origin Austria
Manufacturer Takeda Austria GmbH
Origin Austria
ATC B02BD03

Your comment will appear shortly after approval


Different Units By MoH Code

Feiba 1000IU  MoH 10368 :
Form Powder and solvent for solution for injection/infusion
Packaging Bottle
Package Size 1+1x10ml
Strength 1000IU
Public Price 1223214 L.L.
Stratum E1
NSSF
Quarantine
Reg. Number 83820/1
Submission date 30/08/2020
Registration Year 17/09/2020





Price Comparison

Country: Denmark
Package Size: 1000 enheder
Public Price: 20686.2 DKK ( 268,424,131.20 LBP )
Pack size unit used: 1
Cost/Unit: 20686,2 DKK ( 268,421,536.00 LBP )
Pharmacy Price: 15375 DKK ( 199506000 LBP )
Reference: Danish Medicine Agency
Pricing Date: 19/05/2021
Type: Medicine Authorised

Country: The Netherlands
Package Size: 1
Public Price: 1598.4 EUR ( 154,846,598.40 LBP )
Pack size unit used: 1
Cost/Unit: 1598,4 EUR ( 154,807,848.00 LBP )
Pharmacy Price: 1591.4 EUR ( 154168466.4 LBP )
Reference: Zorginstituut Nederland
Pricing Date: 21/09/2020
Type: Medicine Authorised

Country: Switzerland
Package Size: 1
Public Price: 1469.35 CHF ( 151,960,177.00 LBP )
Pack size unit used: 1
Cost/Unit: 1469,35 CHF ( 151,923,980.00 LBP )
Exfactory Price: 1393.51 CHF
Pricing Date: 04/04/2021
Type: Medicine Authorised

Country: Italy
Package Size: 1
Public Price: 1224.31 EUR ( 118,606,255.56 LBP )
Pack size unit used: 1
Cost/Unit: 1224,31 EUR ( 118,576,224.00 LBP )
Pricing Date: 17/12/2019
Type: Medicine Authorised

Country: Finland
Package Size: 1
Public Price: 1046.06 EUR ( 101,338,108.56 LBP )
Pack size unit used: 1
Cost/Unit: 1046,06 EUR ( 101,332,296.00 LBP )
Reference: Kela
Pricing Date: 22/04/2021
Type: Medicine Authorised

Country: Abu Dhabi
Package Size: 1+1x20 ml
Public Price: 3888.15 AED ( 93,941,592.15 LBP )
Pack size unit used: 1
Cost/Unit: 3888,15 AED ( 93,937,968.00 LBP )
Pharmacy Price: 3381 AED ( 81688341 LBP )
Pricing Date: 27/01/2021
Type: Medicine Authorised

Country: Oman
Package Size: 1000U/20ml
Public Price: 399.38 OMR ( 92,150,544.92 LBP )
Pack size unit used: 1
Cost/Unit: 399,38 OMR ( 92,062,866.00 LBP )
Pricing Date: 19/02/2021
Type: Medicine Authorised

Country: UK
Package Size: 1
Public Price: 780 GBP ( 88,646,220.00 LBP )
Pack size unit used: 1
Cost/Unit: 780 GBP ( 88,646,220.00 LBP )
Reference: DMD
Pricing Date: 08/03/2021
Type: Medicine Authorised

Country: Czech Republic
Package Size: 1+20ml+PREV J
Public Price: 22280.56 CZK ( 85,089,458.64 LBP )
Pack size unit used: 1
Cost/Unit: 22280,56 CZK ( 85,087,320.00 LBP )
Reference: SUKL
Pricing Date: 28/02/2020
Type: Medicine Authorised

Country: Spain
Package Size: 1 vial + 1xdisolvente
Public Price: 850.57 EUR ( 82,399,819.32 LBP )
Pack size unit used: 1
Cost/Unit: 850,57 EUR ( 82,344,600.00 LBP )
Reference: Agencia Española de Medicamentos y Productos Sanitarios
Pricing Date: 06/05/2021
Type: Medicine Non Marketed

Country: KSA
Package Size: 20ml
Public Price: 3246.25 SAR ( 76,741,350.00 LBP )
Pack size unit used: 1
Cost/Unit: 3246,25 SAR ( 76,735,440.00 LBP )
Reference: sfda
Pricing Date: 16/01/2021
Type: Medicine Authorised

Country: Greece
Package Size: 1
Public Price: 781.47 EUR ( 75,705,687.72 LBP )
Pack size unit used: 1
Cost/Unit: 781,47 EUR ( 75,660,156.00 LBP )
Exfactory Price: 678.81 EUR
Pharmacy Price: 689.01 EUR ( 66748532.76 LBP )
Reference: National Organization for Medicines
Pricing Date: 25/02/2021
Type: Medicine Authorised

Country: Norway
Package Size: 1
Public Price: 9004.7 NOK ( 72,974,088.80 LBP )
Pack size unit used: 1
Cost/Unit: 9004,7 NOK ( 72,968,416.00 LBP )
Pharmacy Price: 7034.11 NOK ( 57004427.44 LBP )
Reference: Norwegian Medicine Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Belgium
Package Size: 1Dose
Public Price: 713 EUR ( 69,072,588.00 LBP )
Pack size unit used: 1
Cost/Unit: 713 EUR ( 69,072,588.00 LBP )
Reference: cbip
Pricing Date: 02/12/2020
Type: Medicine Authorised

Country: Sweden
Package Size: 1
Public Price: 7327.01 SEK ( 61,605,500.08 LBP )
Pack size unit used: 1
Cost/Unit: 7327,01 SEK ( 61,605,416.00 LBP )
Pharmacy Price: 7138 SEK ( 60016304 LBP )
Pricing Date: 23/04/2020
Type: Medicine Authorised

Country: Lebanon
Form: Powder and solvent for solution for injection/infusion
Package Size: 1+1x10ml
Public Price: 1223214 LBP ( 1,223,214.00 LBP )
Pack size unit used: 1
Cost/Unit: 1223214 LBP ( 1,223,214.00 LBP )
Pricing Date: 13/06/2024

Country: France
Package Size: 1+1x20 ml
Reference: ansm
Pricing Date: 15/05/2021
Type: Medicine Authorised

Country: New Zealand
Package Size: 1 inj
Exfactory Price: 2630 NZD
Reference: New Zealand Pharmaceutical Management Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries


Note

Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 20686,2 DKK ( 268,421,536.00 LBP )
Cost/Day: DKK ( 0.00 LBP )
Cost/Month: DKK ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 20686,2 DKK ( 268,421,536.00 LBP )
Cost/Day: DKK ( 0.00 LBP )
Cost/Month: DKK ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 20686,2 DKK ( 268,421,536.00 LBP )
Cost/Day: DKK ( 0.00 LBP )
Cost/Month: DKK ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 1598,4 EUR ( 154,807,848.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 1598,4 EUR ( 154,807,848.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 1598,4 EUR ( 154,807,848.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 1469,35 CHF ( 151,923,980.00 LBP )
Cost/Day: CHF ( 0.00 LBP )
Cost/Month: CHF ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 1469,35 CHF ( 151,923,980.00 LBP )
Cost/Day: CHF ( 0.00 LBP )
Cost/Month: CHF ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 1469,35 CHF ( 151,923,980.00 LBP )
Cost/Day: CHF ( 0.00 LBP )
Cost/Month: CHF ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 1224,31 EUR ( 118,576,224.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 1224,31 EUR ( 118,576,224.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 1224,31 EUR ( 118,576,224.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 1046,06 EUR ( 101,332,296.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 1046,06 EUR ( 101,332,296.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 1046,06 EUR ( 101,332,296.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 3888,15 AED ( 93,937,968.00 LBP )
Cost/Day: AED ( 0.00 LBP )
Cost/Month: AED ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 3888,15 AED ( 93,937,968.00 LBP )
Cost/Day: AED ( 0.00 LBP )
Cost/Month: AED ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 3888,15 AED ( 93,937,968.00 LBP )
Cost/Day: AED ( 0.00 LBP )
Cost/Month: AED ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 399,38 OMR ( 92,062,866.00 LBP )
Cost/Day: OMR ( 0.00 LBP )
Cost/Month: OMR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 399,38 OMR ( 92,062,866.00 LBP )
Cost/Day: OMR ( 0.00 LBP )
Cost/Month: OMR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 399,38 OMR ( 92,062,866.00 LBP )
Cost/Day: OMR ( 0.00 LBP )
Cost/Month: OMR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 780 GBP ( 88,646,220.00 LBP )
Cost/Day: GBP ( 0.00 LBP )
Cost/Month: GBP ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 780 GBP ( 88,646,220.00 LBP )
Cost/Day: GBP ( 0.00 LBP )
Cost/Month: GBP ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 780 GBP ( 88,646,220.00 LBP )
Cost/Day: GBP ( 0.00 LBP )
Cost/Month: GBP ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 22280,56 CZK ( 85,087,320.00 LBP )
Cost/Day: CZK ( 0.00 LBP )
Cost/Month: CZK ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 22280,56 CZK ( 85,087,320.00 LBP )
Cost/Day: CZK ( 0.00 LBP )
Cost/Month: CZK ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 22280,56 CZK ( 85,087,320.00 LBP )
Cost/Day: CZK ( 0.00 LBP )
Cost/Month: CZK ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 850,57 EUR ( 82,344,600.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 850,57 EUR ( 82,344,600.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 850,57 EUR ( 82,344,600.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 3246,25 SAR ( 76,735,440.00 LBP )
Cost/Day: SAR ( 0.00 LBP )
Cost/Month: SAR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 3246,25 SAR ( 76,735,440.00 LBP )
Cost/Day: SAR ( 0.00 LBP )
Cost/Month: SAR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 3246,25 SAR ( 76,735,440.00 LBP )
Cost/Day: SAR ( 0.00 LBP )
Cost/Month: SAR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 781,47 EUR ( 75,660,156.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 781,47 EUR ( 75,660,156.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 781,47 EUR ( 75,660,156.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 9004,7 NOK ( 72,968,416.00 LBP )
Cost/Day: NOK ( 0.00 LBP )
Cost/Month: NOK ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 9004,7 NOK ( 72,968,416.00 LBP )
Cost/Day: NOK ( 0.00 LBP )
Cost/Month: NOK ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 9004,7 NOK ( 72,968,416.00 LBP )
Cost/Day: NOK ( 0.00 LBP )
Cost/Month: NOK ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 713 EUR ( 69,072,588.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 713 EUR ( 69,072,588.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 713 EUR ( 69,072,588.00 LBP )
Cost/Day: EUR ( 0.00 LBP )
Cost/Month: EUR ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 7327,01 SEK ( 61,605,416.00 LBP )
Cost/Day: SEK ( 0.00 LBP )
Cost/Month: SEK ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 7327,01 SEK ( 61,605,416.00 LBP )
Cost/Day: SEK ( 0.00 LBP )
Cost/Month: SEK ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 7327,01 SEK ( 61,605,416.00 LBP )
Cost/Day: SEK ( 0.00 LBP )
Cost/Month: SEK ( 0.00 LBP )
Coverage of surgical situations in acquired haemophilia by autoantibodies against factor VIII : (Adults)
Cost/Unit: 1223214 LBP ( 1,223,214.00 LBP )
Cost/Day: LBP ( 0.00 LBP )
Cost/Month: LBP ( 0.00 LBP )
Prevention of hemorrhoids in hemophilia A and B : (Adults)
Cost/Unit: 1223214 LBP ( 1,223,214.00 LBP )
Cost/Day: LBP ( 0.00 LBP )
Cost/Month: LBP ( 0.00 LBP )
Treatment of bleeding episodes in constitutional factor VIII deficiency (hemophilia A) : (Adults)
Cost/Unit: 1223214 LBP ( 1,223,214.00 LBP )
Cost/Day: LBP ( 0.00 LBP )
Cost/Month: LBP ( 0.00 LBP )

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info